News

NOTICE OF EXTRAORDINARY GENERAL MEETING AND FIRST CONTROL MEETING IN ASARINA PHARMA AB (PUBL) 2024-07-22 08:00

The shareholders of Asarina Pharma AB (publ), reg. no. 556698-0750, (the “Company”) are hereby given notice to attend the extraordinary general...

ASARINA PHARMA ANNOUNCES OUTCOME OF PARTNERING PROCESS, CONTROL BALANCE SHEET AND PROPOSAL TO LIQUIDATE 2024-07-18 17:45

Asarina Pharma AB (publ) ("Asarina Pharma” or the ”Company”) today announces that the Company is discontinuing its efforts to find...

Bulletin from the Annual General Meeting of Asarina Pharma AB (publ) 2024-06-27 11:33

The following resolutions were passed at the Annual General Meeting (the “AGM”) of Asarina Pharma AB (publ) (the “Company”) on...

ASARINA PHARMA AB (PUBL) RELEASES ANNUAL REPORT 2023 2024-06-04 22:54 Annual

(Stockholm, 4 June 2024) Asarina Pharma (“the Company”) today announces the release of its 2023 Annual Report. Status and OutlookSince completing...

Asarina Pharma AB announces new date for the release of Annual Report for 2023 2024-05-28 22:00

Asarina Pharma AB (publ) (”the Company”) announces today that the Board has decided to postpone the release of the Annual Report for 2023 to...

Asarina Pharma AB announces new date for the release of Annual Report for 2023 2024-05-21 11:50

Asarina Pharma AB (publ) (”the Company”) announces today that the Board has decided to postpone the release of the Annual Report for 2023 to...

ASARINA PHARMA AB (PUBL) RELEASES YEAR-END REPORT 2023 2024-02-27 08:30 Interim

(Stockholm, 27 February 2024) Asarina Pharma (“the Company”) today releases its Second Half-Year and Year-End Report for 2023. The full Report...

Asarina Pharma AB changes Certified Adviser to Carnegie Investment Bank AB 2023-11-30 10:30

Asarina Pharma AB today announces a change of Certified Adviser from Erik Penser Bank AB to Carnegie Investment Bank AB. The Company has entered into an...

Asarina Pharma updates on partnering and financials 2023-11-16 08:33

Stockholm, 16 November 2023. Asarina Pharma AB (publ., “Asarina” or “the Company”) today provides an update on its partnering activities...

Asarina Pharma AB (publ) releases First Half-Year Report (H1/2023) 2023-08-23 08:30 Interim

(Stockholm, 23 August 2023) Asarina Pharma today releases its First Half-Year Report for 2023. In addition to the financial statements for H1/2023, the...